Prognostic value of the metabolic syndrome in essential hypertension

Journal of the American College of Cardiology

Volumn 43, Issue 10, 2004, Pages 1817-1822

  Schillaci, Giuseppe ^a   Pirro, Matteo ^a   Vaudo, Gaetano ^a   Gemelli, Fabio ^a   Marchesi, Simona ^a   Porcellati, Carlo ^b   Mannarino, Elmo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Perugia General Hospital   (Italy)

Author keywords

Adult Treatment Panel III of the National Cholesterol Education Program; ATP III; blood pressure; BMI; body mass index; BP; CI; confidence interval; hazard ratio; HR; left ventricular; LV; PIUMA; Progetto Ipertensione Umbria Monitoraggio Ambulatoriale

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ARTICLE; ATTENUATION; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONFIDENCE INTERVAL; DIABETES MELLITUS; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE;

ADULT; CARDIOVASCULAR DISEASES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 2442491085     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.12.049     Document Type: Article

References (37)

1. Haffner S., Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation. 108:2003;1541-1545
2. Park Y.W., Zhu S., Palaniappan L., Heshka S., Carnethon M.R., Heymsfield S.B. The metabolic syndrome Prevalence and associated risk factor findings in the u.s. population from the third national health and nutrition examination survey, 1988-1994. Arch Intern Med. 163:2003;427-436
3. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 288:2002;2709-2716
4. The Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 285:2001;2486-2497
5. Sattar N., Gaw A., Scherbakova O., et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 108:2003;414-419
6. Ridker P.M., Buring J.E., Cook N.R., Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events An 8-year follow-up of 14, 719 initially healthy american women. Circulation. 107:2003;391-397
7. Han T.S., Williams K., Sattar N., Hunt K.J., Lean M.E., Haffner S.M. Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome San antonio heart study. Obes Res. 10:2002;923-931
8. Sattar N., Tan C.E., Han T.S., et al. Associations of indices of adiposity with atherogenic lipoprotein subfractions. Int J Obes Relat Metab Disord. 22:1998;432-439
9. Rexrode K.M., Buring J.G., Manson J.E. Abdominal and total adiposity and risk of coronary heart disease in men. Int J Obes. 25:2001;1047-1056
10. Zavaroni I., Mazza S., Dall'Aglio E., Gasparini P., Passeri M., Reaven G.M. Prevalence of hyperinsulinaemia in patients with high blood pressure. J Intern Med. 231:1992;235-240
11. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 21:2003;1011-1053
12. Verdecchia P., Porcellati C., Schillaci G., et al. Ambulatory blood pressure An independent predictor of prognosis in essential hypertension. (erratum appears in Hypertension 1995;25:462) Hypertension. 24:1994;793-801
13. Schillaci G., Reboldi G., Verdecchia P. High-normal serum creatinine is a predictor of cardiovascular risk in essential hypertension. Arch Intern Med. 161:2001;886-891
14. Schillaci G., Verdecchia P., Borgioni C., et al. Predictors of diurnal blood pressure changes in 2, 042 subjects with essential hypertension. J Hypertens. 14:1996;1167-1173
15. Schillaci G., Verdecchia P., Borgioni C., et al. Improved electrocardiographic diagnosis of left ventricular hypertrophy. Am J Cardiol. 74:1994;714-719
16. Verdecchia P., Schillaci G., Borgioni C., et al. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension. J Am Coll Cardiol. 31:1998;383-390
17. Pyörälä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease Results from two population studies in finland. Diabetes Care. 2:1979;131-141
18. Welborn T.A., Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 2:1979;154-160
19. Ducimetiere P., Eschwege E., Papoz L., Richard J.L., Claude J.R., Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia. 19:1980;205-210
20. Fontbonne A., Charles M.A., Thibult N., et al. Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population The paris prospective study, 15-year follow-up. Diabetologia. 34:1991;356-361
21. Despres J.P., Lamarche B., Mauriege P., et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 334:1996;952-957
22. Lehto S., Rönnemaa T., Pyörälä K., Laakso M. Cardiovascular risk factor clustering with endogenous hyperinsulinemia predict death from coronary heart disease in patients with type II diabetes. Diabetologia. 43:2000;148-155
23. Alberti K.G.M.M., Kimmet P.Z. WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus Provisional report of a who consultation. Diabet Med. 15:1998;539-553
24. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 24:2001;683-689
25. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 360:2002;1903-1913
26. Castelli W.P. Epidemiology of coronary heart disease The framingham study. Am J Med. 76:1984;4-12
27. Lind L., Berne C., Lithell H. Prevalence of insulin resistance in essential hypertension. J Hypertens. 13:1995;1457-1462
28. Samuelsson O., Wilhelmsen L., Elmfeldt D., et al. Predictors of cardiovascular morbidity in treated hypertension Results from the primary preventive trial in göteborg, sweden. J Hypertens. 3:1985;167-176
29. Isles C.G., Walker L.M., Beevers G.D., et al. Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertens. 4:1986;141-156
30. Pyörälä M., Miettinen H., Halonen P., Laakso M., Pyörälä K. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men The 22-year follow-up results of the helsinki policemen study. Arterioscler Thromb Vasc Biol. 20:2000;538-544
31. Suzuki M., Shinozaki K., Kanazawa A., et al. Insulin resistance as an independent risk factor for carotid wall thickening. Hypertension. 28:1996;593-598
32. Wong N.D., Sciammarella M.G., Polk D., et al. The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. J Am Coll Cardiol. 41:2003;1547-1553
33. Steinberg H.O., Chaker H., Leaming R., Johnson A., Brechtel G., Baron A.D. Obesity/insulin resistance is associated with endothelial dysfunction Implications for the syndrome of insulin resistance. J Clin Invest. 97:1996;2601-2610
34. Festa A., D'Agostino R. Jr., Howard G., Mykkänen L., Tracy R.P., Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome The insulin resistance atherosclerosis study (iras). Circulation. 102:2000;42-47
35. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease Application to clinical and public health practice. a statement for healthcare professionals from the centers for disease control and prevention and the american heart association. Circulation. 107:2003;499-511
36. Targonski P.V., Bonetti P.O., Pumper G.M., Higano S.T., Holmes D.R. Jr., Lerman A. Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events. Circulation. 107:2003;2805-2809
37. Perticone F., Ceravolo R., Pujia A., et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 104:2001;191-196